Fábio Luiz da Cunha Brito

Fábio Luiz da Cunha Brito

Auto-generated profile, based on publicly available information

Fábio Luiz da Cunha Brito

Center of Excellence in Veterinary Ophthalmology (CEOVET) Recife and Fortaleza Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Veterinary Ophthalmology
Verified
Journal Article
Closed access
PDF file
FBFábio L. da C. Brito
Fábio L. da C. Brito
JVJéssica N. Voitena
Jéssica N. Voitena
TMTatiane O. C. Marinho
Tatiane O. C. Marinho
BMBret A. Moore
Bret A. Moore
Fabiano Montiani-FerreiraFabiano Montiani-Ferreira
Fabiano Montiani-Ferreira

1 December 2021 in Arquivo Brasileiro de Medicina Veterinária e Zootecnia
Verified
Journal Article
Open access
FBF.L.C. Brito
F.L.C. Brito
AKA. Kuner
A. Kuner
JVJ.N. Voitena
J.N. Voitena
TMT.O.C. Marinho
T.O.C. Marinho
The objective of this study was to evaluate the use of cyclosporine 1% alone or associated with oral mucosa transplantation (OMT) in dogs with dry keratoconjunctivitis (KCS). Schirmer Tear Test (STT-1) and Tear Film Osmolarity (TFO) were measured in both eyes of 30 adult dogs (before and 45 days after treatment. The animals were divided into three groups (10 dogs for group): control (normal dogs), group I (GI, treated with 1% cyclosporine alone), and group II (GII, treated with 1% cyclosporine and OMT). All STT-1 and TFO values were subjected to the Shapiro-Wilk normality test, and all were normally distributed. STT-1 and TFO values before and after treatment were subjected to the T-Student Test. The STT‐1 and TFO values of the right eye were subjected to Repeated Measures ANOVA followed by a Tukey Test for comparison between groups I and II. Means with a value of p≤0.05 were considered significant. There was a decreased osmolarity in both groups after treatment. Mean osmolarity in GII (322.60±16.56 mOsm/L) was significantly lower than GI (336.40±5.66 mOsm/L). The OMT associated with cyclosporine 1% improved the osmolarity of the tear film in dogs with KCS with a seeming synergism between the clinical and surgical treatments.

3 April 2024 in OBSERVATÓRIO DE LA ECONOMÍA LATINOAMERICANA
Verified
Journal Article
Open access
PDF file
NSNathalia Fontes de Souto dos Santos
Nathalia Fontes de Souto dos Santos
NMNauro Hudson Monetira
Nauro Hudson Monetira
RFRayssa Dias Faleiro
Rayssa Dias Faleiro
AKAndrea Kuner
Andrea Kuner
FBFabio Luiz da Cunha Brito
Fabio Luiz da Cunha Brito
NDNathalie Moro Bassil Dower
Nathalie Moro Bassil Dower
A pressão intraocular é dada pelo equilíbrio entre a produção e a drenagem do humor aquoso, sendo mensurada através da tonometria. A avaliação da pressão intraocular é um dado de extrema importância na avaliação oftalmológica tanto para diagnóstico como para acompanhamento do tratamento de diversas enfermidades oculares. Diversos fatores intrínsecos e extrínsecos podem alterar pressão intraocular do paciente e, por consequência, a tonometria. O objetivo desse trabalho foi realizar levantamento bibliográfico sobre os principais fatores de interferência na leitura e valores da pressão intraocular na espécie canina.

29 May 2026 in Veterinary Research Communications
Verified
Journal Article
Closed access
FBFábio L. C. Brito
Fábio L. C. Brito
MRMaria F. X. Rocha
Maria F. X. Rocha
JVJéssica N. Voitena
Jéssica N. Voitena
ELEric C. Ledbetter
Eric C. Ledbetter
FMFabiano Montiani-Ferreira
Fabiano Montiani-Ferreira

1 January 2021 in Acta Scientiae Veterinariae
Verified
Journal Article
Open access
PDF file
AAAmanda de Deus Ferreira Alves
Amanda de Deus Ferreira Alves
FBFábio Luiz da Cunha Brito
Fábio Luiz da Cunha Brito
MPMárcia de Figueiredo Pereira
Márcia de Figueiredo Pereira
VJValdemiro Amaro da Silva Júnior
Valdemiro Amaro da Silva Júnior
Background: Extramedullary plasmacytoma is a neoplasm originating from plasmacytes with benign behavior, although it can present malignant characteristics such as local invasion and metastases in some cases. Primary extramedullary plasmacytoma in the third eyelid is rare in humans and animals and has not yet been described in cats. Thus, the goal of the present study is to describe the cytological and histopathological findings of an extramedullary plasmacytoma in a cat's third eyelid.Case: A 5-year-old female feline patient with a history of ocular alteration for approximately 30 days was referred to the ophthalmology service. Upon ophthalmic examination of the left eye, an increase in volume with tissue proliferation was identified in the third eyelid's conjunctiva. A collection of material for cytopathological examination was performed. Numerous plasmocytes and atypical lymphocytes with anisocytosis and anisokaryosis were observed, with a possible neoplastic injury being suggested and referred to the patient for surgical removal of the third eyelid. In the histopathological analysis, it was possible to observe several plasma cells and vascular neoformation along the entire conjunctive margin below the epithelium. The glands, serous and mucous, present in the fragment, revealed areas of intervening plasmacytic infiltrate and a large area close to the hyaline cartilage containing intense plasmacytic inflammatory infiltrate with rare neutrophils and macrophages. There was also a structural breakdown of glandular components and lymphocyte cells with mitosis figures and discrete cellular pleomorphism.Discussion: Plasmacytoma is a rare neoplasm in both dogs and cats. The anatomical regions most frequently affected are the digits, lips, and pinna. Concerning the 3rd eyelid tumor involvement, numerous types of neoplasms have been reported in dogs in the veterinary literature, including transmissible venereal tumor, squamous cell carcinoma, and melanocytoma melanoma, lymphoma, plasmacytoma, hemangioma, hemangiosarcoma, mastocytoma, and myoepithelioma. In cats, the third eyelid is the third site most affected by primary tumors. Adult and elderly animals are the most affected; however, an extramedullary plasmacytoma (PEM) has been reported in an eight-month-old male cat's skeletal muscle. Plasmacytoma aspirates, like other round cells, tend to be highly cellular, the cell morphology has a plasmacytoid aspect, resembling mature cells, the cytoplasm is intensely basophilic, and the round nucleus with an eccentric disposition has thin chromatin and indistinct nucleolus. Binucleate and multinucleate cells are common, and the absence of lymphoglandular corpuscles helps differentiate extramedullary plasmacytoma from lymphomas. Histologically, PEM is similar in dogs, humans, and felines, and variations in mature and immature plasma cells can be seen. The diagnosis of extramedullary plasmacytoma is fundamentally histological, and immunohistochemical analysis can also be performed. Surgical excision with safety margins is the primary type of treatment for neoplasms in the 3rd eyelid, being considered an effective method, as seen in this report, during the patient's follow-up for 13 months, no recurrence or metastasis of the neoplasm was seen. When signs of malignant neoplasms are found, it is recommended to evaluate the indication for chemotherapy before surgery and monitor the case after treatment due to recurrence risk.

2 October 2025 in Archives of Veterinary Science
Verified
Journal Article
Open access
RCRenato Luís Carvalho
Renato Luís Carvalho
Fabiano Montiani-FerreiraFabiano Montiani-Ferreira
Fabiano Montiani-Ferreira
DMDuque Moreno
Duque Moreno
FBFábio Luiz Da Cunha Brito
Fábio Luiz Da Cunha Brito
This study investigated the efficacy of the isolated topical use of 2% dorzolamide eye drops three times a day compared to the combination of 100 µg/ml dexmedetomidine (originally formulated for injectable use and applied topically twice a day) associated with the use of 2% dorzolamide eye drops three times a day, in reducing intraocular pressure (IOP) in dogs diagnosed with glaucoma. A total of 29 dogs with glaucoma and IOP greater than 25 mmHg were selected based on specific clinical criteria of the disease. The dogs were divided into two groups: Group 1 (DORZO) included 12 animals that received only 2% dorzolamide eye drops every eight hours, and Group 2 (DEX DORZO) included 17 animals that received 2% dorzolamide eye drops every eight hours combined with 100 µg/ml dexmedetomidine applied topically every 12 hours. IOP measurements were taken on the day of the first clinical evaluation and again at 7 and 30 days after the glaucoma diagnosis. Vital parameters such as heart rate, respiratory rate, and systolic blood pressure were assessed before and 30 minutes after the topical application of dexmedetomidine. The results showed a significant reduction in IOP in eyes treated with dorzolamide alone (DORZO) and those treated with the combination of dexmedetomidine and dorzolamide (DEX DORZO). The DEX DORZO group had an average reduction of 35.99% (p = 0.001) in IOP at the end of the 30-day evaluation compared to a 20.32% reduction in the DORZO group (p = 0.6026). There were no statistically significant differences in the evaluated vital parameters, and no cases of blepharospasm or hyperemia were observed following medication administration in either group. In conclusion, the topical administration of dexmedetomidine twice daily, combined with dorzolamide eye drops, may be an effective and safe approach to reducing IOP in dogs with glaucoma. These results suggest the potential use of dexmedetomidine as an additional therapeutic option for the treatment of glaucoma in dogs, due to its alpha-2 adrenergic agonist action and the absence of significant adverse effects.